Skip to main content

Table 2 Mean and median per patient costs (in €) at first and second year after diagnosis, stratified by stage at diagnosis, morphology and procedure

From: Renal cell carcinoma: the population, real world, and cost-of-illness

 

First year

Second year*

Total*

n

Mean (S.D.)

Median

Mean Rate

n

Mean (S.D.)

Median

Mean Rate

Mean (S.D.)

Median

Mean Rate

Stage at diagnosis

           

 I

90

14,610 (5415)

13,070

88

2427 (3961)

1167

17,037 (6735)

14,237

 II

14

14,503 (4199)

13,242

0.99

14

4891 (10,189)

1048

2.02

19,394 (11,020)

14,290

1.14

 III

30

22,126 (15,052)

13,683

1.51

28

6320 (10,128)

1587

2.60

28,447 (18,343)

15,270

1.67

 IV

14

26,096 (15,845)

24,688

1.79

8

15,397 (12,675)

11,864

6.34

41,494 (23,069)

36,552

2.44

Histology

           

 Chromophobe

8

13,231 (1002)

13,106

8

1685 (2306)

877

14,917 (2515)

13,983

 Clear cell

94

17,488 (10,577)

13,293

1.32

91

4222 (7087)

1700

2.51

21,709 (12,796)

14,993

1.45

 Non-classified/undifferentiated

2

29,626 (1007)

29,626

2.24

0

29,626 (1007)

29,626

1.99

 Papillary

21

15,331 (8260)

13,350

1.16

20

3552 (6774)

1167

2.11

18,882 (10,790)

14,517

1.27

 Unknown

23

18,095 (11,881)

13,571

1.37

19

5976 (12,039)

1043

3.55

24,070 (17,793)

14,614

1.61

Procedures

           

 Radical nephrectomy

66

21,394 (13,661)

1198

1.52

58

6410 (9802)

1898

2.85

27,804 (10,591)

16,007

1.70

 Partial nephrectomy

76

14,066 (3220)

13,013

76

2249 (3802)

1144

16,315 (3820)

14,157

 Percutaneous ablation

3

17,885 (7923)

12,623

1.27

3

12,935 (17,499)

591

5.75

30,820 (18,087)

13,215

1.89

 None

3

4127 (2779)

4238

0.29

1

730 (0)

730

0.30

4857 (1604)

4968

0.30

Total

148

17,210 (10,312)

13,335

 

138

3934 (7609)

1145

 

21,429 (13,102)

14,606

 
  1. *Weighted by survival time